Cognitive behavioral therapy best for cancer patients with insomnia

Cognitive behavioral therapy best for cancer patients with insomnia

(HealthDay)—Cognitive behavioral therapy for insomnia (CBT-I) is the preferred choice over mindfulness-based stress reduction (MBSR) for nonpharmacologic management of insomnia in patients with cancer, according to a study published online Jan. 6 in the Journal of Clinical Oncology.

Sheila N. Garland, Ph.D., from the University of Pennsylvania Health System in Philadelphia, and colleagues conducted a noninferiority trial involving with cancer with who were randomized to receive either MBSR (64 patients) or CBT-I (47 patients). The intervention occurred from September 2008 to March 2011, with assessments taken at baseline, after the program, and after three months of follow-up. The margin for noninferiority was four points on the Insomnia Severity Index.

The researchers found that immediately after the program, MBSR was inferior to CBT-I for improving insomnia severity (P = 0.35), but at follow-up, MBSR demonstrated noninferiority (P = 0.02). At follow-up, in the CBT-I group, sleep diary-measured sleep onset latency was reduced by 22 minutes, compared with 14 minutes in the MBSR group. Both groups experienced similar reductions in wake after sleep onset. Increases in total sleep time were 0.60 hours in the CBT-I group and 0.75 hours for MBSR.

"Although MBSR produced a clinically significant change in and psychological outcomes, CBT-I was associated with rapid and durable improvement and remains the best choice for the nonpharmacologic treatment of insomnia," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Helping lung cancer patients beat insomnia

Dec 09, 2013

(Medical Xpress)—It is estimated that anywhere from 50 to 80 percent of persons diagnosed with lung cancer experience severe insomnia that may persist for an average of eight years after the initial diagnosis.

Recommended for you

Suppressing a protein reduces cancer spread in mice

1 hour ago

Scientists have found that decreasing the levels of or blocking a specific protein commonly found in humans and many other animals allowed them to slow the spread of two different kinds of cancer to the lungs ...

Bone loss drugs may help prevent endometrial cancer

11 hours ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.